Evidence map›Paper›PMID 35695711›Full record

ReviewProteomics2022

A field guide to the proteomics of post-translational modifications in DNA repair.

Ethan James Sanford, Marcus Bustamante Smolka

Open access · greenAbstract readReview
In one paragraph

Review in Proteomics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ethan James SanfordDepartment of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, USA.
Marcus Bustamante SmolkaDepartment of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, USA.
Cornell University · US

Funding

Coordination of ATR Signaling for Genetic Quality Control, Silencing, and DNA Repair During MeiosisR01HD095296 · NICHD · CORNELL UNIVERSITY · PI Paula Elaine Cohen, Marcus Smolka · 2018 to 2026
$4.2M
Signaling Mechanisms in Genome Maintenance (Equipment Supplement 2023)R35GM141159 · NIGMS · CORNELL UNIVERSITY · PI Marcus Smolka · 2021 to 2026
$3.5M
Cellular Responses to DNA Replication StressR01GM097272 · NIGMS · CORNELL UNIVERSITY · PI SMOLKA, MARCUS · 2011 to 2020
$2.7M
Mechanisms of heterochromatin replicationR01GM123018 · NIGMS · CORNELL UNIVERSITY · PI SMOLKA, MARCUS · 2018 to 2021
$1.2M
NICHD NIH HHS R01 HD095296NIGMS NIH HHS R01 GM097272NIGMS NIH HHS R01 GM123018NIGMS NIH HHS R35 GM141159
6 · The paper itself

Abstract

All cells incur DNA damage from exogenous and endogenous sources and possess pathways to detect and repair DNA damage. Post-translational modifications (PTMs), in the past 20 years, have risen to ineluctable importance in the study of the regulation of DNA repair mechanisms. For example, DNA damage response kinases are critical in both the initial sensing of DNA damage as well as in orchestrating downstream activities of DNA repair factors. Mass spectrometry-based proteomics revolutionized the study of the role of PTMs in the DNA damage response and has canonized PTMs as central modulators of nearly all aspects of DNA damage signaling and repair. This review provides a biologist-friendly guide for the mass spectrometry analysis of PTMs in the context of DNA repair and DNA damage responses. We reflect on the current state of proteomics for exploring new mechanisms of PTM-based regulation and outline a roadmap for designing PTM mapping experiments that focus on the DNA repair and DNA damage responses.

Indexed as

Protein Processing, Post-TranslationalProteomicsDNA DamageDNA RepairMass SpectrometryLC-MS/MS, technology, bottom-up proteomics, technology, signal transduction, cell biologyphosphoproteomics, technology, post-translational modification analysis, technology, post-translational modifications, cell biology, mass spectrometry

Identifiers

PMID35695711
PMCPMC9950963
OpenAlexW4282600895

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.